证券代码：920670 证券简称：数字人 公告编号：2026-003 山东数字人科技股份有限公司 内部控制整改进展暨股票可能被实施退市风险警示的风险 提示公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 重要内容提示： 公司 2024 年度财务报告内部控制被出具否定意见的审计报告，触及《北京 证券交易所股票上市规则》10.4.2 条"（六）首个会计年度财务报告内部控制 被出具无法表示意见或否定意见的审计报告，或者未按照规定披露财务报告内 部控制审计报告"应当立即披露股票可能被实施退市风险警示的风险提示公告 情形。 一、披露股票可能被实施退市风险警示的风险提示公告的原因 2025 年 4 月 27 日公司召开第三届董事会第二十三次会议，审议通过《关 于公司内部控制审计报告》议案。公司于 2025 年 4 月 29 日在北京证券交易所 官网 （http://www.bse.cn）上披露了《内部控制审计报告》（公告编号： 2025-030）。 公司 2024 年度财务报告内部控制被出具否定意见的审计报告， ...

证券代码：920670 证券简称：数字人 公告编号：2026-002 山东数字人科技股份有限公司 2025 年年度业绩预告公告 (二)业绩预告情况 √年度净利润实现扭亏为盈 √年度实现盈利，且净利润与上年同期相比上升 50%以上 二、本期业绩重大变化的主要原因 2025 年度公司归属于上市公司股东净利润变化的主要原因系公司加大市场 单位：万元 项目 本报告期 上年同期 变动比例% 归属于上市 公司 股东的净利润 750.00～850.00 -415.92 280.32%～ 304.37% 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 特别提示：本公告所载 2025 年年度主要财务数据为初步核算数据，未经会 计师事务所审计，具体数据以公司 2025 年年度报告中披露的数据为准，提请投 资者注意投资风险。 一、本期业绩预告情况 (一)业绩预告期间 2025 年 1 月 1 日至 2025 年 12 月 31 日。 开拓和实施力度，实施完成了上年末递延到本期的部分项目以及本期中标项目， 导致收入增加，营业收 ...

作为山东数字人科技股份有限公司(以下简称"公司")独立董事,近日 我们向公司发送了《关于加强年报审计工作的函》。 一、主要内容 鉴于公司2024年度财务报告被年审会计师出具保留意见、内部控制被出具 否定意见,作为公司独立董事,我们本着严格履职、勤勉尽责的工作态度,高 度关注公司2025年度年报审计工作。 近期,全体独立董事与公司年审会计师进行了现场沟通。会上我们向与会 的上会会计师事务所(特殊普通合伙)会计师,表达了对公司2025年报审计工 作的关注,就监管部门前期检查提出的问题,如收入确认、信用政策、发挥内 审部门作用等内容,并关注内控政策制定程序及执行情况,与年审会计师就审 计计划、人员安排、时间进度等进行了沟通。 证券代码:920670 证券简称:数字人 = 中 公告编号:2026-001 山东数字人科技股份有限公司 独立董事关于加强年报审计工作的函的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记 载、误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 《关于加强年报审计工作的函》。 特此公告。 山东数字人科技股份有限公司 独立董事: 2026年 ...

Market Overview - The medical services sector increased by 0.18% on January 21, with Nanmo Biology leading the gains [1] - The Shanghai Composite Index closed at 4116.94, up 0.08%, while the Shenzhen Component Index closed at 14255.12, up 0.7% [1] Top Gainers in Medical Services - Nanmo Biology (688265) closed at 49.79, up 7.01% with a trading volume of 20,000 shares and a transaction value of 98.02 million [1] - Hite Biology (300683) closed at 29.67, up 5.74% with a trading volume of 107,800 shares and a transaction value of 32.2 million [1] - Dean Diagnostics (300244) closed at 26.46, up 5.59% with a trading volume of 796,300 shares and a transaction value of 2.13 billion [1] - ST Zhongzhu (600568) closed at 2.64, up 5.18% with a trading volume of 376,500 shares and a transaction value of 9.81 million [1] - Tongce Medical (600763) closed at 46.51, up 4.99% with a trading volume of 198,600 shares and a transaction value of 911 million [1] Top Losers in Medical Services - Digital Human (920670) closed at 18.72, down 4.44% with a trading volume of 74,500 shares and a transaction value of 143 million [2] - Hongbo Pharmaceutical (301230) closed at 46.36, down 1.88% with a trading volume of 131,200 shares and a transaction value of 614 million [2] - Chengda Pharmaceutical (301201) closed at 41.39, down 1.76% with a trading volume of 36,600 shares and a transaction value of 153 million [2] Capital Flow in Medical Services - The medical services sector saw a net inflow of 50.51 million from institutional investors, while retail investors experienced a net outflow of 375 million [2] - The sector's overall capital flow indicates a strong interest from institutional and speculative investors, with retail investors pulling back [2][3] Notable Capital Inflows - Sanbo Brain Science (301293) had a net inflow of 91.48 million, representing 9.03% of its total capital [3] - Tongce Medical (600763) saw a net inflow of 83.46 million, accounting for 9.16% of its total capital [3] - BGI Genomics (300676) recorded a net inflow of 51.81 million, which is 8.37% of its total capital [3]

证券代码：920670 证券简称：数字人 公告编号：2025-107 山东数字人科技股份有限公司 内部控制整改进展暨股票可能被实施退市风险警示的风险 提示公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 重要内容提示： 公司 2024 年度财务报告内部控制被出具否定意见的审计报告，触及《北京 证券交易所股票上市规则》10.4.2 条"（六）首个会计年度财务报告内部控制 被出具无法表示意见或否定意见的审计报告，或者未按照规定披露财务报告内 部控制审计报告"应当立即披露股票可能被实施退市风险警示的风险提示公告 情形。 一、披露股票可能被实施退市风险警示的风险提示公告的原因 2025 年 4 月 27 日公司召开第三届董事会第二十三次会议，审议通过《关 于公司内部控制审计报告》议案。公司于 2025 年 4 月 29 日在北京证券交易所 官网 （http://www.bse.cn）上披露了《内部控制审计报告》（公告编号： 2025-030）。 公司 2024 年度财务报告内部控制被出具否定意见的审计报告， ...

Market Overview - The Shanghai Composite Index closed at 3968.84 points, above the annual line, with a slight increase of 0.09% [1] - The total trading volume of A-shares reached 24,617.43 billion yuan [1] Stocks Breaking Annual Line - A total of 92 A-shares have surpassed the annual line today, with notable stocks showing significant deviation rates [1] - The stocks with the highest deviation rates include: - Wajingke (8.82%) - Zhangyue Technology (8.44%) - Suoling Co., Ltd. (7.81%) [1] Detailed Stock Performance - The following stocks have notable performance metrics: - Wajingke: 20.00% increase, turnover rate of 14.94%, latest price at 37.80 yuan [1] - Zhangyue Technology: 10.00% increase, turnover rate of 12.20%, latest price at 22.12 yuan [1] - Suoling Co., Ltd.: 10.00% increase, turnover rate of 10.69%, latest price at 6.05 yuan [1] - Other stocks with significant increases include: - Desheng Technology: 10.03% increase - Nanxing Co., Ltd.: 10.00% increase [1] Additional Stocks with Minor Deviations - Stocks with smaller deviation rates that have just crossed the annual line include: - Guifaxiang - Guangkang Biochemical - Shunwang Technology [1]

Market Performance - The medical services sector increased by 0.51% on December 8, with Chengdu XianDao leading the gains [1] - The Shanghai Composite Index closed at 3924.08, up 0.54%, while the Shenzhen Component Index closed at 13329.99, up 1.39% [1] Top Gainers in Medical Services - Chengdu XianDao (688222) closed at 23.20, up 1.75% with a trading volume of 45,700 shares and a turnover of 106 million yuan [1] - Other notable gainers include: - Guangzheng Eye Hospital (002524) at 4.63, up 1.54% [1] - MediXis (688202) at 53.96, up 1.35% [1] - WuXi AppTec (603259) at 91.55, up 1.27% with a significant turnover of 3.33 billion yuan [1] Top Losers in Medical Services - ST Zhongzhu (600568) closed at 2.79, down 2.11% with a trading volume of 614,600 shares and a turnover of 173 million yuan [2] - Other notable losers include: - Haoyuan Pharmaceutical (688131) at 74.35, down 1.50% [2] - Aoyang Health (002172) at 4.20, down 1.41% [2] Capital Flow Analysis - The medical services sector experienced a net outflow of 297 million yuan from institutional investors, while retail investors saw a net inflow of 317 million yuan [2][3] - Notable capital flows include: - WuXi AppTec (603259) with a net outflow of 30.81 million yuan from institutional investors [3] - NuoSiGe (301333) with a net inflow of 11.54 million yuan from institutional investors [3]

证券代码：920670 证券简称：数字人 公告编号：2025-106 山东数字人科技股份有限公司 内部控制整改进展暨股票可能被实施退市风险警示的风险 一、披露股票可能被实施退市风险警示的风险提示公告的原因 2025 年 4 月 27 日公司召开第三届董事会第二十三次会议，审议通过《关 于公司内部控制审计报告》议案。公司于 2025 年 4 月 29 日在北京证券交易所 官网 （http://www.bse.cn）上披露了《内部控制审计报告》（公告编号： 2025-030）。 公司 2024 年度财务报告内部控制被出具否定意见的审计报告，触及《北京 证券交易所股票上市规则》10.4.2 条"（六）首个会计年度财务报告内部控制 被出具无法表示意见或否定意见的审计报告，或者未按照规定披露财务报告内 部控制审计报告"应当立即披露股票可能被实施退市风险警示的风险提示公告 情形。敬请广大投资者注意投资风险。 二、公司股票可能被实施退市风险警示的风险提示 根据《北京证券交易所股票上市规则》第 10.4.2 条第(六)项规定,上市公 司出现"首个会计年度财务报告内部控制被出具无法表示意见或否定意见的审 1 计报告，或者未按照 ...

New Stock Listings - Nant Technology (920124) listed at an issue price of 8.66 on November 27, 2025[1] - Tianpu Co., Ltd. (605255) is in the offer period from November 20 to December 19, 2025[1] - Jianglong Shipbuilding (300589) and Huasheng Lithium Battery (688353) reported significant abnormal fluctuations[1] Abnormal Fluctuations - Multiple companies including ST Wanfang (000638) and ST Dongyi (002713) have reported abnormal trading activities[2] - Companies such as ST Suwu (600200) and ST Yanshan (000608) are also under scrutiny for unusual market behavior[3]

Core Viewpoint - The stock of Digital People (920670) experienced a rise of 4.49% with a trading volume of 271 million yuan and a turnover rate of 21.92% on the day, indicating significant trading activity and interest from institutional investors [2] Trading Activity Summary - The stock's turnover rate of 21.92% led to its listing on the trading board, with institutional investors net buying 4.953 million yuan [2] - The top five trading departments accounted for a total transaction volume of 67.2652 million yuan, with a net selling amount of 5.0235 million yuan [2] - Among the trading departments, one institutional seat was noted for a net purchase of 4.953 million yuan, with a buying amount of 6.604 million yuan and a selling amount of 1.651 million yuan [2] Historical Performance - Over the past six months, the stock has appeared on the trading board eight times, with an average price increase of 0.02% the day after being listed and an average decline of 5.38% over the following five days [2]